0      0

25th Napa Pain Conference

Parmacotherapy for Pain

Aug 19, 2018 9:00am ‐ Aug 19, 2018 10:00am

Credits: None available.



  • Review components of the 2016 CDC Opioid Prescribing Guidelines
  • Comparing analgesic effect between opioids and non-opioids
  • Risks of addiction
  • Hyperalgesia
  • Common neuropathic medications
  • Topical Medications
  • NMDA receptor antagonists
  • Beta blockers
  • Botulinum toxin
  • Cannabinoids

Additional Reading

  • Brune, K. (1986). Comparative pharmacology of ’non-opioid’ analgesics. Medical Toxicology, 1, 1-9.
  • Staahl, C., Olesen, A. E., Andresen, T., Arendt-Nielsen, L., & Drewes, A. M. (2009). Assessing
    efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated
    review. British Journal of Clinical Pharmacology, 68(3), 322-341.
  • White, P. F. (2005). The changing role of nonopioid analgesic techniques in the management of
    postoperative pain. Anesthesia & Analgesia, 101(5S), S5-S22.
  • Martin, T. J., & Eisenach, J. C. (2001). Pharmacology of opioid and nonopioid analgesics in chronic pain states. Journal of Pharmacology and Experimental Therapeutics, 299(3), 811-817.
  • Gloth, F. M. (2011). Pharmacological management of persistent pain in older persons: focus on
    opioids and nonopioids. The Journal of Pain, 12(3), S14-S20.
  • Katzung, B. G., Masters, S. B., & Trevor, A. J. (Eds.). (2004). Basic & Clinical Pharmacology.


  • Dr. Steven Richeimer, MD, Chief, Division of Pain Medicine, Keck School of Medicine, University of Southern California


Credits: None available.

You must be logged in and own this session in order to post comments.